News Release

Tobacco Will Kill One Third Of Chinese Men

Peer-Reviewed Publication

BMJ

(Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths)

Click below to download PDF document
You will require Acrobat Reader to view file.
Click here for PDF document

(Emerging tobacco hazards in China: 2. Early mortality results from a prospective study)

Click below to download PDF document
You will require Acrobat Reader to view file.
Click here for PDF document

China now consumes one third of the world's cigarettes. In this week's BMJ researchers report on the largest-ever investigation on the hazards of tobacco. Involving one and a quarter million Chinese, the study finds that on current smoking patterns, at least one third (100 million) of Chinese males now aged 0-29 years will be killed by tobacco related diseases in middle or old age.

The study also reveals that the pattern of disease caused by smoking varies widely both within China and between China and the developed world. Of deaths caused by tobacco in China, 45 per cent are from chronic lung disease, 15 per cent from lung cancer and five to eight per cent from each of oesophageal cancer, stomach cancer, liver cancer, stroke, ischaemic heart disease and tuberculosis.

Two thirds of men now become smokers before age 25; few give up and about half of those who persist will be killed (about half of all persistent cigarette smokers in Britain and America are eventually killed by tobacco). Tobacco currently causes 13 per cent of deaths in men but only three per cent of deaths in women. This, explain the authors, is because the proportion of young women who smoke is currently small.

The study concludes that if current smoking patterns persist in China, then such projections cannot be substantially wrong. The research is a long-term collaboration between the Clinical Trial Service Unit, Oxford University, the Chinese Academies of Preventive Medicine and of Medical Sciences in Beijing and Cornell University in the USA, supported by the Imperial Cancer Research Fund, the UK Medical Research Council, the US National Institutes of Health, the Canadian Government and the World Bank.

Contact:

Margaret Willson, press officer for Oxford University CTSU

t: (0)1536 772181
f: (0)1536 772191
m: (0)973 853347
m.willson@dial.pipex

###



Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.